Error loading player: No playable sources found
Speed to Patients - Factory of the Future / Agile Manufacturing and Testing
Date
January 27, 2022
This product is not available for individual purchase, but it is available as part of the following products:
This session is a continuation of Wednesday’s Speed to Patient Plenary Session. This session includes talks on novel strategies for manufacturing and testing products. It will also include a session from the EMA to discuss opportunities to gain approval for these novel strategies.
Speed pursued without considering the impact to people (burnout) and resources (shortages) is not sustainable. During the session we will hear input on strategies to take on manufacturing and testing in a new way. You are encouraged to share your experiences and to ask questions to determine how these strategies could be applied to others within industry. Our shared goal is to ensure patients have sustainable and fast access to safe and efficacious therapies.
Session Speakers:
08:30 - 08:55
Process Analytics for mRNA Process Development - Letting the Data Do the Work
V Elliott Schmitt, Moderna, Inc.
08:55 - 09:20
Translating Innovation in Pharmaceutical Manufacturing and Technologies for the Benefit of Patients - An EU Perspective
V Veronika Jekerle, European Medicines Agency
09:20 - 09:45
Opportunities and Challenges for Decentralized Manufacturing
V Christine Moore, ORGANON
09:45 - 10:00
Discussion – Questions and Answers
Speed pursued without considering the impact to people (burnout) and resources (shortages) is not sustainable. During the session we will hear input on strategies to take on manufacturing and testing in a new way. You are encouraged to share your experiences and to ask questions to determine how these strategies could be applied to others within industry. Our shared goal is to ensure patients have sustainable and fast access to safe and efficacious therapies.
Session Speakers:
08:30 - 08:55
Process Analytics for mRNA Process Development - Letting the Data Do the Work
V Elliott Schmitt, Moderna, Inc.
08:55 - 09:20
Translating Innovation in Pharmaceutical Manufacturing and Technologies for the Benefit of Patients - An EU Perspective
V Veronika Jekerle, European Medicines Agency
09:20 - 09:45
Opportunities and Challenges for Decentralized Manufacturing
V Christine Moore, ORGANON
09:45 - 10:00
Discussion – Questions and Answers
Session Chairs
Speakers
General
Tracks
Related Products
QbD: Bridging from the Past to the Future
FDA initiated “Pharmaceutical Quality for the 21st Century” about 20 years ago…
Next Steps from Speed to Patients
In today’s world being able to supply medicines to patients faster is not only a competitive advantage but of critical importance for saving lives…
“Alone We Can Do So Little, Together We Can Do So Much” - How Did 25 Years of WCBP Conferences Shape Our Thinking and Our Way of Working?
“Alone we can do so little, together we can do so much” is a Helen Keller quote which captures the spirit of CASSS-organized conferences like WCBP, the regional CMC strategy forums, and technology specific meetings…
